MedTrace Logo

Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries

NCT05872087 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-05-24

No results posted yet for this study

Summary

Comparative study between nebulised dexmedetomidine and nebulized midazolam in reducing preoperative anxiety and emergence delirium in children undergoing lower abdominal surgeries

Conditions

  • Emergence Delirium
  • Anxiety Preoperative

Interventions

DRUG

Nebulised Dexmeditomidine

premedication by dexmeditomidine 3mcg/kg in children undergoing lower abdominal surgeries

DRUG

Nebulised Midazolam

premedication by nebulised midazolam 0.3mg/kg in children undergoing lower abdominal surgeries

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-01
Primary Completion
2023-09-01
Completion
2024-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05872087 on ClinicalTrials.gov